Novel 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators

Details for Australian Patent Application No. 2006252781 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Bignan, Gilles C.; Orsini, Michael J.; Connolly, Peter J.; Battista, Kathleen A.; Liu, Jessica J.; Middleton, Steven A.

Agent Shelston IP

Pub. Number AU-A-2006252781

PCT Pub. Number WO2006/130416

Priority 60/686,857 02.06.05 US

Filing date 25 May 2006

Wipo publication date 7 December 2006

International Classifications

A61K 31/4747 (2006.01) - spiro-condensed

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/130416 Priority application(s): WO2006/130416

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006252783-Tigecycline and methods of preparation

2006252780-Methods and meter electronics for rapidly detecting a non-uniformity of a material flowing through a coriolis flowmeter